COMMUNIQUÉS West-GlobeNewswire

miRagen Therapeutics Announces Initiation of Phase 2 Clinical Trial of MRG-201
10/07/2018
BOULDER, Colo., July 10, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced [...]
Amydis Receives Parkinson’s Disease Grant from Michael J. Fox Foundation
10/07/2018
SAN DIEGO, July 10, 2018 (GLOBE NEWSWIRE) -- Amydis, Inc., a privately-held pharmaceutical company developing proprietary chemistry and innovative approaches for the detection of amyloid-related diseases, announced [...]
AxoGen, Inc. Appoints Lisa N. Colleran to Board of Directors
10/07/2018
Health care industry veteran brings 30+ years of executive experience to AxoGen, Inc. Board of Directors ALACHUA, Fla., July 10, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and [...]
Arbutus Presents Corporate Update on Key Milestones
10/07/2018
First Subject Dosed in Phase 1 Study of AB-506, Arbutus’ Second-Generation Capsid Inhibitor All-Oral Combination Study of AB-506 and AB-452 Expected in 2019 HBsAg Reduction Data from ARB-1467 Expected in Q4 Arbutus [...]
Ossur Hf : Q2 2018 Results - Conference call Thursday 26 July at 9:00 CET
10/07/2018
Announcement no. 44/2018 10 July 2018 Conference call on Thursday 26 July at 9:00 CET / 7:00 GMT / 3:00 EDT Össur will publish its financial results for Q2 2018 prior to market opening on Thursday 26 July. That same day [...]
ImmuCell Announces Preliminary Sales Results for Second Quarter of 2018
10/07/2018
PORTLAND, Maine, July 10, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq:ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Achillion Initiates Phase I First-in-Human Study of ACH-5548, a Third Oral Small Molecule Inhibitor of Complement Factor D
10/07/2018
- Additional clinical compounds expand factor D portfolio opportunities - NEW HAVEN, Conn., July 10, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a clinical-stage pharmaceutical company [...]
Transactions in relation to share buyback program
10/07/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Helsinn: Glenmark Pharmaceuticals expands its oncology franchise in India with the launch of Helsinn’s AKYNZEO®, a combination drug for the prevention of chemotherapy-induced nausea and vomiting (CINV)
10/07/2018
Glenmark Pharmaceuticals expands its oncology franchise in India with the launch of Helsinn’s AKYNZEO ® , a combination drug for the prevention of chemotherapy-induced nausea and vomiting (CINV) AKYNZEO ® was developed [...]
SPINEWAY : Implementation of the new strategic plan Signature of a financing agreement
10/07/2018
Implementation of the new strategic plan Signature of a financing agreement with Alpha Blue Ocean for a reserved issue of OCEANE (bonds convertible into new or existing shares) with attached warrants As announced on 13 [...]
SPINEWAY : Mise en place du nouveau plan stratégique signature d'un contrat de financement
10/07/2018
Mise en place du nouveau plan stratégique Signature d'un contrat de financement avec Alpha Blue Ocean par émission réservée d'OCEANE assorties de BSA Conformément à l'annonce du 13 juin 2018, SPINEWAY, spécialiste des [...]
Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver
10/07/2018
The agreement aims to develop and market software solutions to aid physicians' in their treatment recommendations and follow-up care for liver cancer. Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am [...]
Guerbet et IBM Watson Health annoncent un partenariat stratégique alliant l'intelligence artificielle à l'imagerie médicale
10/07/2018
L'accord vise à développer et commercialiser une solution logicielle d'aide au diagnostic et au suivi dans le cancer du foie. Villepinte (France) et Cambridge (Etats-Unis) - le 10 juillet 2018 (8:30 CEST) - Guerbet, [...]
Shire plc : Rule 2.9 announcement
10/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 10 July 2018 Shire [...]
MediciNova Announces Clinical Data from Subgroup Analyses of Completed Clinical Trial of MN-166 (ibudilast) in ALS
10/07/2018
LA JOLLA, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]
Mesa Labs Declares Quarterly Dividend
10/07/2018
Lakewood, Colorado, July 09, 2018 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of [...]
Helix BioPharma Corp. Closes Private Placement
09/07/2018
RICHMOND HILL, Ontario, July 09, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) (FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Adamas Announces New Employment Inducement Grant
09/07/2018
EMERYVILLE, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the compensation committee of the company’s board of directors granted two new employees the option [...]
TRIO Awarded NATALEE Study, Largest Single Phase III Breast Cancer Clinical Trial in its History
09/07/2018
Ribociclib Combination Therapy in Adjuvant Setting Represents A Promising Therapy Against Breast Cancer EDMONTON, Alberta, July 09, 2018 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO) today announced a [...]

Pages